ECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logo
  • Home
  • Archives
  • Contact
✕
  • Filter by
  • Categories
  • Tags
  • Authors
  • Show all
  • All
  • Advocacy
  • Anal cancer
  • Artificial intelligence (AI)
  • Bladder cancer
  • Brain cancer
  • Breast cancer
  • Colorectal cancer
  • ComboMATCH
  • Esophagus cancer
  • Gallbladder cancer
  • Head and neck cancer
  • Health equity
  • Immunotherapy
  • In memory
  • Kidney cancer
  • Leukemia
  • Liver cancer
  • Lung cancer
  • Lymphoma
  • Mammography
  • Melanoma
  • Myelodysplastic syndrome
  • Myeloma
  • NCI-MATCH
  • Older adults
  • Pancreatic cancer
  • Pancreatic cysts
  • Patient education
  • Patient navigation
  • Patient-reported outcomes
  • Penis cancer
  • Personalized treatment
  • Policy
  • Precision medicine
  • Prevention
  • Prostate cancer
  • Real-world data/evidence
  • Research results
  • Sarcoma
  • Screening for cancer
  • Side effects
  • Survivorship
  • Targeted therapy
  • Upper tract urothelial cancer
  • Young adults
July 24, 2025
Research dictionary entry
July 24, 2025
Categories
  • Trial Results

Trial Results: ECOG-ACRIN research round-up – Summer 2025

Takeaways from ECOG-ACRIN trials presented at the 2025 American Society of Clinical Oncology Annual Meeting
Do you like it?
0 Read more
May 19, 2025
May 19, 2025
Categories
  • Editorials

Building a lasting bond: Your oncologist as partner through good and bad times

Four tips for creating and maintaining a strong patient-oncologist relationship
Do you like it?
1 Read more
May 19, 2025
May 19, 2025
Categories
  • New Trials

Now Enrolling: The PTCL-STAT research study is testing the use of stem cell transplants for patients with an aggressive type of lymphoma

This study is for patients who are in remission after their initial treatment for peripheral T-cell lymphoma
Do you like it?
0 Read more
May 19, 2025
May 19, 2025
Categories
  • Ongoing Trials

Ongoing Trials: A closer look at ECOG-ACRIN’s studies for patients with head and neck cancer

These four actively recruiting clinical trials are exploring possible new treatment approaches
Do you like it?
0 Read more
Prev page
1234567891011121314151617
Next page

News, editorials, and perspectives for the cancer research advocacy community

✕

Categories

  • Editorials
  • New Trials
  • Ongoing Trials
  • Trial Results

Resources

  • Active ECOG-ACRIN Trials
  • Advocacy Organizations
  • Myths and Facts
STAY UP TO DATE

Subscribe to receive updates from the ECOG-ACRIN advocacy committee.

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2026 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc